Fette Tablet Press Designed for High Production

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-10-02-2014
Volume 38
Issue 10

Fette Compacting America FE75 Tablet Press is designed to produce up to 1.6 million tablets per hour.

Fette Compacting America’s FE75 Tablet Press can be equipped with up to 115 punch stations to produce more than 1.6 million tablets per hour. The FE75 features four compression rollers with a control system for direct compression, enabling the machine to operate with two intermediate pressures.

The system measures two square meters, with a double-sided rotary press to allow users to press single- and double-layer tablets and powder. The FE75 includes pneumatically controlled tablet scrapers, conical filling units, tubeless extraction unit, and chassis complete with a two-part frame structure and a pneumatic suspension system.

Fette Compacting America
www.fetteamerica.com

Articles in this issue
Ross-856927-1416898025646.jpg
Ross Agitated Vessel Includes Silicone Heating Blankets
Analytical Method Comparability in Registration and Post-Approval Stages: A Risk-Based Approach
Analytical Method Comparability in Registration and Post-Approval Stages: A Risk-Based Approach
Wechsler_Jill-856790-1416898146268.jpg
Biopharma Manufacturers Respond to Ebola Crisis
Determining Facility Mold Infection
romacokilianktp-856928-1416898023256.jpg
Romaco Kilian's Tablet Press Introduces Continuous Weight Control
GEA-856930-1416898019279.jpg
GEA Pharma Systems Valves Contain Powders
figure1-856883-1417773790013.jpg
Packaging Addresses Cold-Chain Requirements
Fluorination Remains Key Challenge in API Synthesis
Fluorination Remains Key Challenge in API Synthesis
Fette-856929-1416898021360.jpg
Fette Tablet Press Designed for High Production
Marrying Big Data with Personalized Medicine
Marrying Big Data with Personalized Medicine
Morris_marilyn-856679-1416897342957.jpg
Bolstering Graduate Education and Research Programs
Solving Poor Solubility with Amorphous Solid Dispersions
Solving Poor Solubility with Amorphous Solid Dispersions
The Role of Normal Data Distribution in Pharmaceutical Development and Manufacturing
The Role of Normal Data Distribution in Pharmaceutical Development and Manufacturing
Milmo_Sean-856903-1416898033486.jpg
Harmonizing Marketing Approval of Generic Drugs in Europe
AlphaG-gd-858224-1416895790953.jpg
Meissner's Filtration System Allows Scalability
Recent Videos
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology
Behind the Headlines episode 6
Behind the Headlines episode 5
Related Content
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Orexo and Abera Partner to Develop Nasal Powder Vaccines

Feliza Mirasol
December 20th 2024
Article

The companies will use Orexo’s powder-based drug delivery technology to develop mucosal vaccines in an inhaled formulation.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

TOP NEWS on grunge world map | Image Credit: © Sean K - © Sean K - stock.adobe.com

Novo Nordisk to Establish New Production Facility for Rare Disease Therapies in Denmark with DKK 8.5 Billion Investment

Feliza Mirasol
December 17th 2024
Article

Novo Nordisk will use the DKK 8.5 billion (US$1.2 billion) to build a new modular and flexible production facility in Odense, Denmark, that will produce multiple products for rare diseases.

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

March 26th 2024
Podcast

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Novo Nordisk Gains Manufacturing Sites from Novo Holdings and Novavax while EC Approves Catalent Acquisition

Feliza Mirasol
December 11th 2024
Article

The European Commission has approved Novo Holdings' acquisition of Catalent, which includes the related sale of three manufacturing sites to Novo Nordisk, which is also acquiring the Czech Republic manufacturing site of Novavax for $200 million.

3D printed pills and drugs, future of medicine. 3D Printing Drugs In Pharmacies. Multi-colored, various drugs, pills, capsules. Pharmaceutical medical concept | Image Credit: © irissca - © irissca - stock.adobe.com

Legal and Regulatory Perspectives on 3D Printing: Drug Compounding Applications

Gary Ritchie;Sharon Flank
December 10th 2024
Article

This paper explores the legal and regulatory framework around 3D drug printing, particularly for personalized medicine, considering regulatory compliance, business concerns, and intellectual property rights.